Background: Genome-wide association studies (GWASs) have identified
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To whom correspondence should be addressed: The SNPs that influence gene expression levels as mentioned above are called expression quantitative trait loci (eQTLs). eQTLs are useful for considering function of non-coding SNPs, however this approach only achieves indirect evidence because eQTL effects are usually determined by correlations between genotypes and expression levels of target genes [14] . One of the molecular mechanisms to explain eQTL effects is contact between eQTLs and target genes by the formation of chromatin loops.
Chromatin regions including eQTLs fold in order to bring in proximity to the genes they regulate. A growing body of evidence indicates that disease-associated variants in enhancers affect the expression levels of distal genes via chromatin loops in several diseases such as frontotemporal lobar degeneration, which belongs to the group of neurodegenerative diseases that includes AD [15] [16] [17] [18] . These findings suggest that non-coding AD SNPs may alter the functions of regulatory sequences, such as enhancers that typically regulate gene expression levels via chromatin loops. Thus, we hypothesized that non-coding AD SNPs are located in enhancers and affect gene expression levels.
To test this hypothesis, we analyzed 392 AD SNPs located in non-coding regions by integrating enhancer activity data and chromatin interaction data. In particular, we used data from the Encyclopedia of DNA Elements (ENCODE) project [19] and the Roadmap Epigenomics project [20] . These projects measured epigenomic markers, including histone modifications and DNase I-hypersensitive sites, across every human tissue or cell type, and used these data to estimate genome-wide chromatin states (e.g., whether an enhancer is activated or not) [21, 22] . To identify chromatin-chromatin interactions such as chromatin loops, we used data from the chromosome conformation capture (3C) variant Hi-C, which can capture genome-wide chromatin interactions via high-throughput sequencing. We found that nearly 30% of the non-coding AD SNPs were located in enhancers and that they affected the expression of genes associated with Aβ clearance, synaptic transmission, and immune responses. Among the non-coding AD SNPs, rs1476679 at the ZCWPW1 gene locus and rs7364180 at the CCDC134 gene locus were associated with several expression quantitative trait locus (eQTL) genes.
Finally, analysis of chromatin higher-order structure revealed direct associations between rs1476679 and eQTL genes. Our findings would explain the regulatory mechanism of this AD SNP.
Results
Nearly 30% of non-coding AD SNPs are located in enhancers Figure 1 provides an overview of our study. First, we collected AD SNPs from the GWAS catalog database [23] . These AD SNPs have GWAS p-values of less than 1.00 × 10 −6 , which is used as a suggested threshold in GWAS. Among the 406 AD SNPs, 392 SNPs (96.6%) were in non-coding regions, whereas the rest were missense and synonymous mutations ( Figure 2A) . Next, we checked whether these non-coding AD SNPs were located in enhancers, using publicly available enhancer data. Enhancer locations were predicted based on 11 histone modifications and DNase I-hypersensitive sites quantified in 127 human tissues or cell types, including ten brain tissues (see Methods). We counted non-coding AD SNPs located in the enhancers that were predicted in one or more tissues or cell types. Among the 392 non-coding AD SNPs, 106 (27.0%) were in enhancers ( Figure 2B ). Of these 106 SNPs, 40 (10.2% of the 392 non-coding AD SNPs) were in enhancers identified in one or more brain tissues.
Genes affected by non-coding AD SNPs are related to AD-relevant processes and are often differentially expressed in AD patients
Next, we investigated whether the non-coding AD SNPs functioned as eQTLs, which affect gene expression levels. To this end, the genes influenced by the non-coding AD SNPs (hereafter referred to as eQTL genes) were collected from the Table S3) ). We counted the number of the eQTL genes that were identified as the DEGs. To test whether the DEGs significantly include the eQTL genes, we performed 10,000 bootstrap replications in each brain tissue in each dataset and obtained the expected number of eQTL genes that are included in the DEGs.
We calculated Z-scores and p-values from the number of eQTL genes and the expected numbers. Our results showed that the eQTL genes were significantly included among the DEGs in all these tissues with the exception of the cerebellum (Z-score > 0, p-value < 0.05) ( Table 2 ). The DEGs in the cerebellum had fewer the eQTL genes than them in the other brain tissues in the same dataset. These results are reasonable, as the cerebellum remains unaffected in Braak staging, which represents the pathological degree of AD [31] . Among the 126 eQTL genes analyzed in these datasets (4 of the 130 eQTL genes were not analyzed in the datasets because those corresponding probe sets
were not constructed in the microarray or those transcripts did not satisfy criteria in RNA-seq), 110 genes (87.3%) were differentially expressed in one or more brain tissues or datasets. Additionally, 35 of 46 SNPs (76.1%) had one or more these differentially expressed eQTL genes. These results suggested that the non-coding AD SNPs affected genes whose expression levels were altered in the AD brain.
AD SNPs with eQTL effects are often located at protein-binding sites
Enhancers are regulatory regions that control the expression levels of surrounding genes when bound by specific proteins, such as transcription factors (TFs).
To emphasize that the non-coding AD SNPs are located in the enhancers, we looked for TF-binding sites in these enhancers using the ENCODE ChIP-seq data for 161 TFs from 91 human cell types, which included 17 brain tissues or cell types (Additional file 4: Supplementary Table S4) . Among the 46 SNPs with eQTL effects discussed above,
19 were located at a protein-binding site in at least one cell types (Table 3) . The closest genes were the corresponding eQTL genes for only eight of these SNPs, indicating that GWAS SNPs do not always affect the closest genes ( Table 3) . Four SNPs of the SNPs (rs4663105, rs1532278, rs4147929, and rs439401) were located around well-known AD candidate genes (BIN1, CLU, ABCA7, and APOE) and were eQTLs of those genes. The BIN1 locus rs4663105 was located in enhancer that was activated in five tissues or cell types. Interestingly, all of these tissues or cell types were from brain regions including the hippocampus, suggesting that rs4663105 has the brain-specific eQTL effects (Additional file 5: Supplement Table S5 ). An enhancer near CLU locus was activated in 63 tissues or cell types including 4 brain tissues. The APOE locus rs439401 is located in the APOE-APOC1 intergenic region. Enhancers near rs439401 were activated in 102 tissues or cell types including 7 brain tissues (Additional file 5: Supplement Table S5 ). Table S6 ). Furthermore, 13
SNPs in SK-N-SH and 14 SNPs in U-251 MG co-localized in the same TAD with more than 80% of the eQTL genes associated with that particular SNP. These results suggested that the AD SNPs might regulate eQTL genes in the same TAD through chromatin higher-order structures.
AD SNPs associating with many eQTL genes are located in CTCF-binding sites
We found that rs1476679 and rs7364180 SNPs were associated with a particularly large number of eQTL genes (23 and 25, respectively) in Table3. Supplementary Table S8 ). CTCF is a key factor to form chromatin loops and protects promoters against acting by chance from distant enhancers [41] . Table S9 ). Furthermore, we used DNase-seq data to identify CTCF-binding at DNase I-hypersensitive sites (DHSs) (i.e., open-chromatin regions) (31 tissues or cell lines; Additional file 10: Supplement Table S9 ). The bottom panel in Figure 5B shows the peak scores for CTCF-binding sites and DHSs. As expected, we Taken together, our results from the chromatin higher-order structure analysis showed that rs1476679 spatially contacted several eQTL genes via chromatin loops and that rs1476679 likely affects PILRB and GATS, which were reported as the eQTL genes of rs1476679 in previous studies, through enhancer-promoter interactions. These enhancer-promoter interactions were supported by bindings of various TFs near the rs1476679 region and bindings of RNAPII in upstream of PILRB and GATS.
The impact of rs7364180 on many of its eQTL genes may be indirect
Finally, we used a similar analysis to identify chromatin loops formed by rs7364180. We found that rs7364180 significantly interacted with CCDC134 and its adjacent genes MEI1 and SREBF2 (Additional file 13: Supplement Figure S4A) ; however, no long-range chromatin interactions with the other eQTL genes were identified. These results suggested that rs7364180 does not directly influence the expression levels of most of its eQTL genes. However, SREBF2 showed strong eQTL effects with rs7364180 in several brain tissues (Additional file 13: Supplement Figure   S4B ). To examine the genes that are regulated by SREBF2, whose product is a TF, we used TRRUST, which is a TF-target interaction database based on text mining and manual curation [47] . This analysis showed that SREBF2 regulates 20 genes that are significantly associated with AD (FDR = 1.60 × 10 -6 ) (Additional file 14: Supplement Table S10 , Additional file 15: Supplement Table S11 ). Therefore, many of the eQTL genes identified for rs7364180 may be indirectly affected by the change in SREBF2 expression.
Discussion
Previous GWASs have found AD-candidate SNPs, however, how these AD SNPs act to the pathogenesis is little known. In this study, we attempted to uncover those functions, considering epigenetic effects from chromatin higher-order structure.
We confirmed our hypothesis that many non-coding AD SNPs are located in enhancers and affected the expression levels of surrounding genes. We also investigated chromatin higher-order structure with the aim of revealing direct interactions between the AD SNPs and eQTL genes through TCC experiments. We report the following findings: (1) nearly 30% of non-coding AD SNPs are located in enhancers; (2) the eQTL genes of the non-coding AD SNPs within enhancers are associated with Aβ formation, synaptic transmission, immune responses, and AD status; (3) rs1476679 and rs7364180 are associated with a particularly large number of eQTL genes; and (4) rs1476679 spatially interacts with many eQTL genes via chromatin loops.
Our findings revealed that rs1476679 is not only found in the enhancer but also directly interacts with eQTL genes through chromatin loops. In addition to PILRB and GATS, which were reported in previous studies 
Conclusions
In conclusion, multi-omics data analyses, including analyses of histone modifications, eQTL associations, protein binding, and chromatin higher-order structure EnhAc shows low H3K4me1 and high H3K27ac levels.
Expression quantitative trait loci (eQTLs)
The eQTL genes of each AD SNP were searched in the GTEx Portal database 
Differentially expressed genes (DEGs) from publicly available datasets
DEGs between AD and non-demented brains were identified using three publicly available gene expression datasets (syn5550404 
Chromatin interaction analysis
To identify significant chromatin interactions, we applied the R software package fourSig [45] . We counted mapped reads from TCC to the nearest restriction sites (HindIII sites) because TCC assumes that chromatin interactions occur around restriction sites. A viewpoint nearest to the HindIII sites on both sides of the SNP was selected when we detected chromatin interactions for an SNP. A window size of one fragment was set. The significance level employed was an FDR-adjusted p-value of 0.05.
Identification of topologically associated domains (TADs)
Identification of TADs in the SK-N-SH and U-251MG cell lines was performed using the R software packages HiCdat and HiCseg 
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Supplementary Information Cell culture
We used two cell lines for this study; a neuroblastoma cell line, SK-N-SH (American Type Culture Collection, Manassas, VA, USA), and an astrocytoma cell line, U-251MG (Japan Collection of Research Bioresources Cell Bank, Ibaraki, Osaka, Japan). SK-N-SH was grown in Eagle's MEM medium supplemented with 10% FBS, 1 mM sodium pyruvate, 0.1 mM each non-essential amino acids and antibiotics (Gibco(R) Penicillin-Streptomycin, 10,000 U/mL (Life Technologies)). U-251MG was grown in Eagle's MEM medium supplemented with 10% FBS and antibiotics. Both cell lines were cultured at 37°C with 5% CO 2 .
TCC library preparation
A TCC library was prepared according to a method reported by Kalhor et al. with minor modifications [1] . The cells were cross-linked with 2 % formaldehyde on 10 minutes incubation, and then 2 M glycine was added to a final concentration of 125 mM to stop the reaction. Since cells stuck strongly to the culture dish during the crosslinking reaction, which made it hard to harvest them, they were washed twice using PBS(-) and then treated with trypsin-EDTA (0.25% trypsin and 1 mM EDTA, Invitrogen) for 15 minutes at 37 °C. The dishes were chilled on ice and the cells were harvested by pipetting on ice to avoid proteolysis. To isolate nuclei, cells were suspended in 50 mL of ice-cold lysis buffer (10 mM Tris-HCl, pH 8.0, 10 mM NaCl, 1 % IGEPAL CA-630 (Sigma), and 1/500 (vol/vol) protease inhibitor cocktail (Nacalai Tesque)), stirred for 90 min at 4 °C and then centrifuged at 1,600 g [2, 3] . Nuclei were suspended in wash buffer 1 (50 mM Tris-HCl, pH 8.0, 50 mM NaCl and 1 mM EDTA). The suspension was incubated for 10 minutes at 65 °C after the addition of 95 µL 2 % SDS. After that, 105 µL 25 mM iodoacetyl-PEG2-biotin (IPB) (Thermo Fisher Science) was added, followed by incubation for 40 minutes at room temperature to biotinylate cysteine residues. Chromatin was digested with HindIII (New England Biolabs) overnight at 37 °C with rotation. After digestion, the mixture was placed in a Slide-A-Lyzer Dialysis Cassette (20K MWCO) (Pierce Protein
Research Products, Rockford, Illinois) and dialyzed for four hours at room temperature against 1 L of the TE buffer (10 mM Tris-HCl, pH 8.0, 1 mM EDTA) to remove IPB remaining from the biotinylation step. The TE buffer was renewed after three hours.
Digested chromatin was immobilized on 0.4 mL Dynabeads(R) MyOne Streptavidin T1 beads (Invitrogen) to remove non-crosslinked DNA fragments. The magnetic beads were treated with neutralized IPB and then washed twice with wash buffer 2 (10 mM Tris-HCl, pH 8.0, 50 (hg19) using Bowtie2 [6] . The reads of 25 bp were mapped at first. If the reads were not mapped uniquely, they were extended to 30 bp and re-mapped. This extension and re-mapping process was repeated until the read length of 75bp was reached. To remove non-informative pairs, the following read pairs were removed: (1) self circles (both reads mapped in the same restriction fragment), (2) dangling ends (sum of the distances between read and corresponding HindIII recognition site more than 500 bp), and (3) redundant (which may result from PCR amplification). We used a library "hiclib" (provided by the Leonid Mirny laboratory (https://bitbucket.org/mirnylab/)) for these filtering steps. The processing steps described above were carried out with our in-house computational pipeline.
Expression quantitative trait loci (eQTL)
The GTEx Portal database provides SNPs associated with gene expression from 449
individuals not restricted to specific diseases or conditions in 44 diverse postmortem tissues. 
